Beifang Ning
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Hepatology top 2%
- Epidemiology top 10%
- Topics
- Liver physiology and pathology (11 papers)MicroRNA in disease regulation (10 papers)Liver Disease Diagnosis and Treatment (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Beifang Ning
36 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.4k
- Cancer Research 929
- Oncology 509
- Hepatology 488
- Epidemiology 359
Countries citing papers authored by Beifang Ning
This map shows the geographic impact of Beifang Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beifang Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beifang Ning more than expected).
Fields of papers citing papers by Beifang Ning
This network shows the impact of papers produced by Beifang Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beifang Ning. The network helps show where Beifang Ning may publish in the future.
Co-authorship network of co-authors of Beifang Ning
This figure shows the co-authorship network connecting the top 25 collaborators of Beifang Ning. A scholar is included among the top collaborators of Beifang Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beifang Ning. Beifang Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 7 | |
| 3 | 3 | |
| 4 | 100 | |
| 5 | 61 | |
| 6 | 181 | |
| 7 | 104 | |
| 8 | 185 | |
| 9 | 255 | |
| 10 | 16 | |
| 11 | 94 | |
| 12 | 23 | |
| 13 | 87 | |
| 14 | 91 | |
| 15 | 48 | |
| 16 | 69 | |
| 17 | 194 | |
| 18 | 28 | |
| 19 | 27 | |
| 20 | 17 |
About Beifang Ning
Beifang Ning is a scholar working on Hepatology, Cancer Research and Gastroenterology, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Liver physiology and pathology (11 papers), MicroRNA in disease regulation (10 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Cancer Research (929 citations), Hepatology (488 citations) and Molecular Biology (1.4k citations). Beifang Ning has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jin Ding, Wei‐Fen Xie, Hongyang Wang, Wen Sun, Kun Wu, Daimin Xiang, Junping Zhang, Cheng Chen, Chuan Yin and Xiuliang Cui. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.